“Interleukin-37 suppresses the cytotoxicity of hepatitis B virus peptides-induced CD8+ T cells in patients with acute hepatitis B” (2023) Biomolecules and Biomedicine, 23(3), pp. 527–534. doi:10.17305/bjbms.2022.8260.